Cdk2/Cyclin Inhibitory Peptide I

Names

[ Name ]:
Cdk2/Cyclin Inhibitory Peptide I

Biological Activity

[Description]:

Cdk2/Cyclin Inhibitory Peptide I (Tat-LFG), a CDK2 inhibitor, kills U2OS osteosarcoma cells in a dose-dependent manner[1].

[Related Catalog]:

Research Areas >> Cancer

Signaling Pathways >> Cell Cycle/DNA Damage >> CDK

[Target]

CDK2[1].

[In Vitro]

Cdk2/Cyclin Inhibitory Peptide I (0-150 µM; 24 h) kills U2OS osteosarcoma cells in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: U2OS osteosarcoma cells Concentration: 0-150 µM Incubation Time: 24 h Result: Exhibited good activity to kill U2OS osteosarcoma cells.

Chemical & Physical Properties

[ Molecular Formula ]:
C₁₁₁H₁₉₆N₄₈O₂₃

[ Molecular Weight ]:
2571.05

Cdk2/Cyclin Inhibitory Peptide I

Names

Biological Activity

Chemical & Physical Properties

Related Compounds